Jun 27, 2021
Compound Tested for Alcoholic Liver Disease
Posted by Jason Blain in category: biotech/medical
Investigators at Cedars-Sinai and UC San Diego found that a synthetic compound given orally protected the liver against injury in an animal model for alcoholic hepatitis.
The study, co-authored by Dr. Ekihiro Seki, was published in the Proceedings of the Na… See More.
The most prevalent forms of ALD are fatty liver, alcoholic hepatitis and cirrhosis. Corticosteroids are the only treatment option for alcoholic hepatitis, or chronic inflammation of the liver, despite little evidence of long-term efficacy and considerable adverse side effects.
Continue reading “Compound Tested for Alcoholic Liver Disease” »